ADDITIONAL INFO

FOXO4-DRI — Cellular Senescence & Protein-Interaction Research Peptide

FOXO4-DRI is a synthetic peptide designed to disrupt the FOXO4–p53 interaction, providing researchers with a precise tool to study cellular senescence, stress-response signaling, and cell cycle regulation. It is widely applied in in-vitro and preclinical studies exploring aging-associated pathways, senescent cell clearance, and intracellular mechanisms involved in tissue maintenance and longevity biology.

For in‑vitro laboratory research only. Not a drug, food, cosmetic, or veterinary product. Not for human or animal administration.

Product Details

Compound Name: FOXO4-DRI
Net Contents: 10 mg lot-dependent (commonly supplied as lyophilized peptide per vial) (3mL)
Form: Lyophilized powder
Purity: ≥98% (HPLC tested; Certificate of Analysis available)
Primary Targets: FOXO4–p53 protein interaction, senescence signaling pathways
Manufactured in: GMP-compliant facility
Intended Use: Laboratory research use only — not for human or veterinary use

Storage & Handling

• Store sealed at −20 °C, protected from light and moisture

• Short-term storage: 2–8 °C in sealed vials

• Allow vial to reach room temperature before opening

• Reconstitute under sterile conditions using appropriate buffers

• Avoid repeated freeze–thaw cycles

• Consult SDS for safety and handling guidance

Research Applications

FOXO4-DRI is commonly used in laboratory and preclinical studies to investigate:

• Cellular senescence and aging-associated pathways

• FOXO4–p53 protein interaction dynamics

• Cell cycle regulation and stress signaling mechanisms

• Selective clearance of senescent cell populations (research models)

• Molecular processes involved in tissue maintenance and longevity biology